Figure 3.
Figure 3. TTP to symptomatic myeloma stratified based on risk factors (immunoparesis, eHb GBTM, eMP GBTM, and edFLC GBTM). The median times to progression for 0, 1, 2, or ≥3 risk factors were not reached: 77, 26, and 13 months, respectively (P <.0001).

TTP to symptomatic myeloma stratified based on risk factors (immunoparesis, eHb GBTM, eMP GBTM, and edFLC GBTM). The median times to progression for 0, 1, 2, or ≥3 risk factors were not reached: 77, 26, and 13 months, respectively (P <.0001).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal